Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 9065 - 9072 of 11616 results
Massachusetts Earned Sick Time Law Takes Effect July 1
May 7, 2015| Alert| Viewpoint
ML Strategies: 21st Century Cures Initiative and Pioneer ACO Expansion
May 7, 2015| Blog| Viewpoint
ONC Releases Privacy and Security Guidance Geared Toward Small Providers
May 7, 2015| Blog| Viewpoint
Breaking Down the DOJ Cybersecurity Unit’s Guidance on Responding to Cyberattacks
May 7, 2015| Blog| Viewpoint
Quick Update on the Obama Administration's Efforts to Update the FLSA White Collar Exemptions
May 6, 2015| Blog| Viewpoint
Maximizing Use of the USPTO's Patent Application Alert Service
May 6, 2015| Blog| Viewpoint
EPA’s Proposed Nano Rule: What Should You Be Doing Now?
May 6, 2015| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.